semaglutide step Two-year effects of in adults with overweight or obesity: the 5 trial 🚨 STEP UP Trial: Higher-dose

(2025) trial specifically tested semaglutide as an add-on to AID systems and found a 4.8 percentage point improvement in time in range (from 69.4% to 74.2%) alongside an 11.3-unit daily reduction in insulin, without any increase in hypoglycemia

Literature [1] Brass, E.P

This biological approach is at the heart of modern metabolic health

* Correspondence: Peijun Liu, [email protected] These authors have contributed equally to this work Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers

Those with objective evidence of disease control (normal fecal calprotectin, endoscopic remission) may be better candidates than those with frequent flares or active inflammation